Patents by Inventor Christopher J. Sweeney

Christopher J. Sweeney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patient support apparatus with side rail
    Patent number: 11992446
    Abstract: A patient support apparatus that comprises a frame and a side rail mounted to the frame. The side rail comprises a side rail body and a pair of arms mounting the side rail body for rotational movement relative to the frame. The pair of arms has a pair of upper pivot connections connected to the side rail body and a pair of lower pivot connections for mounting to the frame. The upper pivot connections engage a timing link.
    Type: Grant
    Filed: September 30, 2022
    Date of Patent: May 28, 2024
    Assignee: Stryker Corporation
    Inventors: Brian J. Tessmer, Christopher Ryan Sweeney, Jeffrey C. Shiery, Michael T. Brubaker, Dickson J. Brubaker, Dan George Parker
  • Drug Combinations to Treat Cancer
    Publication number: 20160082019
    Abstract: This invention relates to the combination of cabozantinib and abiraterone to treat cancer, particularly castration resistant prostate cancer.
    Type: Application
    Filed: April 4, 2014
    Publication date: March 24, 2016
    Inventors: Christopher J. Sweeney, Phili W. Kantoff
  • Use of parthenolide to inhibit cancer
    Patent number: 6890946
    Abstract: The invention provides a method comprising the use of parthenolide, including its analogs, to treat cancer or conditions characterized by abnormal angiogenesis.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: May 10, 2005
    Assignee: Indiana University Research and Technology Corporation
    Inventors: Harikrishna Nakshatri, Christopher J. Sweeney
  • Use of parthenolide to inhibit cancer
    Publication number: 20030125373
    Abstract: The invention provides a method comprising the use of parthenolide, including its analogs, to treat cancer or conditions characterized by abnormal angiogenesis.
    Type: Application
    Filed: June 21, 2002
    Publication date: July 3, 2003
    Inventors: Harikrishna Nakshatri, Christopher J. Sweeney